Drug Shortage Report for TARO-CARBAMAZEPINE
| Report ID | 39237 |
| Drug Identification Number | 02407515 |
| Brand name | TARO-CARBAMAZEPINE |
| Common or Proper name | TARO CARBAMAZEPINE |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | DORMANT |
| Active Ingredient(s) | CARBAMAZEPINE |
| Strength(s) | 200MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100'S |
| ATC code | N03AF |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-10-15 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2022-12-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.